• JIJI, STAFF REPORT

  • SHARE

The health ministry has decided to let men under 30 who received Moderna Inc.’s COVID-19 vaccine for their first shot switch to Pfizer Inc.’s vaccine for their second.

The decision, made Friday during a meeting of experts, took into account the higher incidence of heart muscle inflammation in young people who received the Moderna shot than those who were given the Pfizer inoculation.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)